Study on the Microbial Environment of Non-small Cell Lung Cancer Based on Mycogenomics and Its Clinical Relevance
NCT07783971 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2026-08-25
Summary
This study aims to uncover the characteristics of the fungal flora in non-small cell lung cancer, and to investigate the relationship between pulmonary fungi and the various pathological subtypes, stages, clinical features of non-small cell lung cancer, as well as patient prognosis. It seeks to provide new perspectives for a comprehensive understanding of non-small cell lung cancer, as well as new approaches for its early diagnosis and prognosis assessment.
Conditions
- Fungal Diseases
- Lung Cancer (NSCLC)
- Microbioata
Sponsors & Collaborators
-
958th Army Hospital of the Chinese People's Liberation Army
lead OTHER
Eligibility
- Min Age
- 30 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-01
- Primary Completion
- 2028-01-30
- Completion
- 2028-08-01
Countries
- China
Study Locations
More Related Trials
-
A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer
NCT05250817 ·Status: COMPLETED
-
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
NCT05673798 ·Status: COMPLETED
-
NGS Combined With RNAseq on Tumor Immune Escape in NSCLC
NCT03764917 ·Status: UNKNOWN
-
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062 ·Status: RECRUITING
-
Multiomics Tumor Evolution Model of NSCLC
NCT05352035 ·Status: RECRUITING
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
A Multi-Centre, Prospective, Non-Interventional Study to Intensively Monitor the Safety of Osimertinib in Clinical Practice Among Chinese NSCLC Patients
NCT03485326 ·Status: COMPLETED
-
Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance
NCT05933863 ·Status: COMPLETED
-
Efficacy Study of Osimertinib in Treatment-naïve Patients With EGFR Mutant NSCLC According to TP53 Mutational Status.
NCT05785208 ·Status: RECRUITING ·Phase: PHASE4
-
Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
NCT01517971 ·Status: COMPLETED
-
Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC
NCT04699721 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Brigatinib as Preferred First Therapy for Adults With Non-Small Cell Lung Cancer (NSCLC) ENTIRETY
NCT05735327 ·Status: ACTIVE_NOT_RECRUITING
-
Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer
NCT06752408 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study to Learn About Brigatinib Treatment Information Available in Chinese Participants With Non-Small-cell Lung Cancer (NSCLC)
NCT05721950 ·Status: ACTIVE_NOT_RECRUITING
-
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China
NCT03059641 ·Status: COMPLETED
-
Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer
NCT07328945 ·Status: RECRUITING
-
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
NCT07026669 ·Status: RECRUITING
-
Osimertinib With or Without Savolitinib as 1L in de Novo MET+, EGFR+ NSCLC
NCT05163249 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Prospective Study of Firmonertinib as First-line Adaptive Therapy Guided by Dynamic ctDNA (MRD) Changes in Locally Advanced or Metastatic EGFR-mutated Non-small Cell Lung Cancer
NCT07661173 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Microbiome in Immunotherapy naïve NSCLC Patients Receiving PD-1/L1 Blockade (MIP_NSCLC)
NCT04636775 ·Status: RECRUITING
-
The Patient-Reported Outcomes in ALK Positive Advanced NSCLC in China
NCT06586801 ·Status: NOT_YET_RECRUITING
-
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
NCT05872763 ·Status: COMPLETED
-
Study on the Mechanism of Acquired Resistance of Entrectinib
NCT07199959 ·Status: RECRUITING
-
An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing
NCT07141771 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation
NCT04322890 ·Status: RECRUITING ·Phase: PHASE2